Company: RNST
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0000715072-25-000234
Chunk: 9

Company: RENASANT CORP
Filing Date: 2025-11-07
Form: 10-Q
Item: Item 1
Chunk 9
---
 share)— — — — (14,217)— (14,217)Common stock issued in public offering7,187,500 35,938 — 181,062 — — 217,000 Issuance of common stock for stock-based compensation awards8,604 — 283 (439)— — (156)Stock-based compensation expense— — — 3,273 — — 3,273 Balance at September 30, 202463,564,028 $332,421 $(97,251)$1,488,678 $1,063,324 $(129,094)$2,658,078 

See Notes to Consolidated Financial Statements.

5

Renasant Corporation and Subsidiaries

Consolidated Statements of Cash Flows (Unaudited)

(In Thousands)

 Nine Months Ended September 30, 20252024Operating activitiesNet income$102,324 $150,710 Adjustments to reconcile net income to net cash provided by operating activities: Provision for credit losses96,522 6,673 Depreciation, amortization and accretion13,167 23,780 Deferred income tax (benefit) expense(4,103)2,494 Gain on sale of MSR(1,467)(3,472)Gain on sale of insurance agency— (53,349)Funding of mortgage loans held for sale(1,220,267)(1,053,190)Proceeds from sales of mortgage loans held for sale1,198,088 954,133 Gains on sales of mortgage loans held for sale(15,086)(14,233)Debt prepayment benefit— (56)(Gains) losses on sales of premises and equipment(347)11 Stock-based compensation expense13,527 10,639 Increase (decrease) in other assets251 (8,108)Decrease in other liabilities(18,278)(1,712)Net cash provided by operating activities164,331 14,320 Investing activitiesPurchases of securities available for sale(1,058,969)(60,656)Proceeds from sales of securities available for sale686,485 177,185 Proceeds from call/maturities of securities available for sale203,429 66,310 Proceeds from call/maturities of securities held to maturity78,918